COMPASS Pathways plc (CMPS)

Intra-Cellular Therapies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	221.88	165.08	220.2	143.21	273.24	190.33
Cash & Short-Term Investments	221.88	165.08	220.2	143.21	273.24	190.33
Cash Growth	-2.95%	-25.03%	53.76%	-47.59%	43.56%	662.35%
Other Receivables	-	21.82	28.93	15.62	11.22	5.78
Receivables	-	21.82	28.93	15.62	11.22	5.78
Prepaid Expenses	54.14	0.28	1.89	2.82	3.36	3.15
Restricted Cash	0.38	0.39	0.44	0.18	0.1	0.03
Other Current Assets	-	13.72	9.84	29.83	7.38	3.11
Total Current Assets	276.4	201.29	261.3	191.65	295.3	202.4
Property, Plant & Equipment	4.34	2.2	4.73	2.62	4.09	0.25
Long-Term Investments	-	0.47	0.47	0.47	0.53	0.53
Long-Term Deferred Tax Assets	4.29	3.77	3.34	2.22	0.77	0.22
Long-Term Deferred Charges	-	5.74	5.96	-	-	-
Other Long-Term Assets	8.5	0.2	0.2	0.33	0.21	0.06
Total Assets	293.54	213.67	275.99	197.29	300.9	203.46
Accounts Payable	10.93	12.28	5.89	4.76	2.56	2.75
Accrued Expenses	10.37	13.17	10.26	8.67	10.04	3.49
Current Portion of Long-Term Debt	7.98	5.51	-	-	-	-
Current Portion of Leases	2.05	1.73	2.41	1.51	2.24	-
Current Income Taxes Payable	-	-	-	-	-	0.24
Other Current Liabilities	-	1.33	1.04	0.66	0.27	0.41
Total Current Liabilities	31.33	34.02	19.6	15.6	15.11	6.9
Long-Term Debt	22.95	24.65	28.76	-	-	-
Long-Term Leases	2.3	0.3	1.88	0.42	1.38	-
Total Liabilities	130.98	58.97	50.24	16.01	16.49	6.9
Common Stock	0.95	0.7	0.64	0.44	0.44	0.37
Additional Paid-In Capital	767.19	704.92	621.65	458.83	444.75	279.48
Retained Earnings	-591	-534.73	-379.61	-261.15	-169.64	-97.9
Comprehensive Income & Other	-14.58	-16.19	-16.93	-16.84	8.87	14.61
Total Common Equity	162.56	154.7	225.74	181.28	284.41	196.56
Shareholders' Equity	162.56	154.7	225.74	181.28	284.41	196.56
Total Liabilities & Equity	293.54	213.67	275.99	197.29	300.9	203.46
Total Debt	35.29	32.19	33.05	1.93	3.61	-
Net Cash (Debt)	186.59	132.89	187.15	141.28	269.63	190.33
Net Cash Growth	-4.80%	-28.99%	32.47%	-47.60%	41.67%	4809.13%
Net Cash Per Share	2.33	1.97	3.67	3.33	6.74	11.20
Filing Date Shares Outstanding	93.34	92.67	64.23	42.76	42.02	36.67
Total Common Shares Outstanding	93.34	68.55	61.94	42.63	42.02	35.93
Working Capital	245.08	167.28	241.69	176.06	280.19	195.51
Book Value Per Share	1.74	2.26	3.64	4.25	6.77	5.47
Tangible Book Value	162.56	154.7	225.74	181.28	284.41	196.56
Tangible Book Value Per Share	1.74	2.26	3.64	4.25	6.77	5.47
Machinery	-	-	-	-	0.75	0.43
Leasehold Improvements	-	-	-	-	0.01	0.01

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q